The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients
about
Biomarkers of Alzheimer's diseaseCeramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ AccumulationBrain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's diseaseBiomarkers in translational research of Alzheimer's diseaseCurrent Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.Multimodal techniques for diagnosis and prognosis of Alzheimer's diseaseHFE gene variants, iron, and lipids: a novel connection in Alzheimer's diseaseThe diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging.Study of OH radicals in human serum blood of healthy individuals and those with pathological schizophrenia.Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controlsMeasuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?Inability of plasma and urine F2A-isoprostane levels to differentiate mild cognitive impairment from Alzheimer's disease.Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update.Isoprostanes: novel bioactive products of lipid peroxidation.Gene-environment interplay in neurogenesis and neurodegeneration.F2-isoprostanes as markers of oxidative stress in vivo: an overview.Lipids and the pathogenesis of Alzheimer's disease: is there a link?Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models.Electrophilic cyclopentenone isoprostanes in neurodegeneration.F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease.Protection against beta-amyloid induced abnormal synaptic function and cell death by Ginkgolide JThe chemistry of Alzheimer's disease.Oxidative balance score, colorectal adenoma, and markers of oxidative stress and inflammation.F2-isoprostanes as markers of oxidant stress: an overview.Inhibition of neuroblastoma cell proliferation with omega-3 fatty acids and treatment of a murine model of human neuroblastoma using a diet enriched with omega-3 fatty acids in combination with sunitinib.Cilostazol prevents amyloid β peptide(25-35)-induced memory impairment and oxidative stress in mice.Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure.Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease.Oxidant stress is increased during treatment of human immunodeficiency virus infection.The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target.Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice.Why is the amyloid beta peptide of Alzheimer's disease neurotoxic?Beneficial effect of Toona sinensis Roemor on improving cognitive performance and brain degeneration in senescence-accelerated mice.Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.Apolipoprotein E genotype and neurological disease onset in Niemann-Pick disease, type C1.
P2860
Q24650667-F30985F2-9790-4C29-BD10-3E4D654FF08FQ28087030-1EEC7949-4D1B-4820-A6D5-18C09A06670EQ28345684-3CA0EE99-D323-4A9C-A332-10266CAA65BAQ33556189-E1F4AE74-5758-4200-8161-3D43DA2C0062Q33590723-9722EAD4-A882-49D9-89D2-D4DB710CDE7CQ33607535-BF8F63B5-78EA-4974-B8B5-8F80E711BC53Q33861622-FE368BB5-B241-49C3-A975-0DA173D297E4Q34296479-54346917-D542-4AFB-A0C7-1B361D15FAD0Q34578112-9C382CE4-2A29-47BE-A01A-D82A00A18F3FQ34763280-9DB15033-E389-432E-B917-E473B10818E6Q35047134-7793B5DE-F117-4826-A429-22ED5EB93818Q35564737-CE154E69-C131-494D-9389-E4C0E01A9EBCQ35738877-2F3DB2B1-4D19-466C-A17C-F6E057309B21Q35754084-3586FA34-1E75-41B7-9C55-546D9587834AQ36003798-C5398B81-DD65-4C7D-8681-9A53E24F6F52Q36317981-AF4C9D10-E909-42E3-B498-31A6E2849DDFQ36508071-A363B04A-9D2B-4268-BBEB-F05AFD206AB3Q36761675-A07263CF-B415-4A9A-BD8B-D0AA1A087717Q36954194-FA7A0041-E7B7-4272-9E6C-0309FAB62F5AQ36954208-DB825B9D-A202-4CBA-89E1-5AF71814ABB4Q37105481-77BA8982-8914-4A09-8192-2AAEBB8150A4Q37582258-6DE08BF0-E5E1-4C90-ABB5-6F79A09012D1Q37648699-DE94BC8B-F7C9-4231-923B-18097E3A8068Q38050392-AAE6FDC2-B15B-453A-8CB6-C938A49A459DQ39410149-CA435736-B4F3-4575-8403-2387A3B4255CQ41485665-756E4815-5EF2-4323-8A37-F851113AB7D8Q42486014-787E6F2B-4954-4D16-94E9-1B22C553869BQ44124964-7A0A2F98-BC9F-486E-B62F-D91786507772Q44702089-46DD86BB-CC8E-4DC7-B6E0-B698DD1A48E4Q45904642-2DC9D1D1-031C-4057-B118-52A64A9E6350Q46588746-9FF5A3B4-4A45-49E8-A7D3-9C85DA2816E7Q46729329-E36A9DD4-A2FD-40E5-A7AE-971C145F989FQ48440952-9273894C-20EF-4063-95ED-FECD63CACA66Q48721515-D83087F6-E308-4E3F-90C3-2A0DF9AD72DFQ53333346-CE91F0DA-FC5B-4FE8-BEAB-63B46D4F2298
P2860
The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
The magnitude of brain lipid p ...... n Alzheimer's disease patients
@ast
The magnitude of brain lipid p ...... n Alzheimer's disease patients
@en
type
label
The magnitude of brain lipid p ...... n Alzheimer's disease patients
@ast
The magnitude of brain lipid p ...... n Alzheimer's disease patients
@en
prefLabel
The magnitude of brain lipid p ...... n Alzheimer's disease patients
@ast
The magnitude of brain lipid p ...... n Alzheimer's disease patients
@en
P2093
P2860
P1476
The magnitude of brain lipid p ...... n Alzheimer's disease patients
@en
P2093
J D Morrow
L J Roberts
S C Sanchez
T J Montine
W R Markesbery
P2860
P304
P356
10.1016/S0002-9440(10)65185-1
P407
P577
1999-09-01T00:00:00Z